Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia - sprookjes - yvandenbroek - TriplyDB

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

http://www.wikidata.org/entity/Q34158520

about

T cell responses in hepatitis C virus infection: historical overview and goals for future research Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?DLA class II alleles and haplotypes are associated with risk for and protection from chronic hepatitis in the English Springer spaniel Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors.Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).Update on hepatitis C virus-specific immunity HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance.Immunity and hepatitis C: a review.Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development.HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Adaptive immunity to the hepatitis C virus.Host genetics in immune-mediated hepatitis C virus clearance.Role of stress-induced NKG2D ligands in liver diseases.Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Innate and adaptive genetic pathways in HCV infection.Hepatitis C-A clinical review.Human leucocyte antigen class I and II imputation in a multiracial population.Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.Characterisation of Mhc class I and class II DRB polymorphism in red-bellied tamarins (Saguinus labiatus).Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection.

P2860

Q27003510-B7EF3870-3B79-4235-B403-6ED0ED1901D3 Q27010312-E80721EE-E19D-4989-B4D7-B6A52B44B888 Q28391462-4A3ED46B-FD32-4065-9513-DB2291C64667 Q30590832-3768985E-3B9C-484E-8815-2C126237D0BA Q33350754-A27BE4F0-876F-444D-AE1C-C5ED68CEC61C Q33796039-FF501F62-F00F-4FFE-A383-136E752909A7 Q34055276-9976D7F9-C94E-402B-955B-5CEAEB4DC075 Q34181287-A09346C0-A4DD-4965-9086-E037A03407DC Q34369562-5F962EF0-D563-427F-96BC-D7ED0BC29096 Q34493947-9AF6EF16-E874-4CB3-A98D-A8C41EA8158E Q35000910-86DC6292-4D14-4E16-9668-385BB11A0E23 Q35275215-2F2DBF8C-BA3B-416E-8CB7-35CF27FBB56F Q35350883-18244448-B9D6-4A6D-805C-2D5B9B410645 Q35374519-EC40A017-64CC-42C6-B4E2-A06DA1469739 Q35446259-5AC28783-0318-4C73-B76A-E6B61D159EAA Q35531173-E7B5D855-8396-472C-AFD8-85CC8A06DEBF Q35737580-9D2E0669-A7A4-49CD-A964-0580F87FE1E3 Q35839496-6578CFBA-2001-4ACE-9BCE-EF3F2DE3AB93 Q36221533-27BF9E58-3D77-45DC-A20E-12B3EF7A145A Q36594965-3161D0AD-72EB-4149-B4C7-F301F3277D61 Q36609717-03534A61-CDE8-4258-AEF3-56326F3AE8D0 Q36921188-A926F5D0-2CD7-47B0-AAEE-6F18C0533C2F Q37046078-992B171E-968D-4A41-A05F-2938C7D27155 Q37138377-FBA2D419-FE98-40DB-9581-5E253A8137AB Q37166509-5026E66F-5F66-4C06-BC5B-3D7CB9774CF2 Q37281576-745F2114-F7F0-4F69-A539-47DDA12A49CC Q37354049-677FD54A-F214-460A-931D-2B7AA9B47AE4 Q37402195-3600A6C1-0139-4BC8-B7A6-F5E265F25327 Q37540482-06B2895B-792C-4AE4-9A0F-6339CE9051DA Q37805839-87C501B7-3E6E-4218-97E8-E4A3B08F0207 Q37862746-B3F69584-FAE5-49F8-946E-B7A010A09389 Q37957971-8736C493-858F-4993-A430-9C1F79B658DF Q37964746-B2072EFD-D9F3-4B26-B2AD-83D7DAC0AD8C Q38010203-E17B0839-5E17-41E3-B989-0F384037DDE7 Q38364524-EBD7AABF-A4A3-41D9-A1D2-CD8333841EB3 Q38812892-EAAADD24-5886-44F6-B20B-C67461BA2372 Q39255932-E3EBFC0F-63FC-41AC-9C49-F7BD5F03F692 Q40943814-B96642D7-0459-499C-BF62-07D267AAE0BF Q42605390-12E88CBE-4225-4C19-B1C3-1BFA7D621B51 Q42978256-B645D585-8998-4E17-A1DF-3A65DD2D2BEE

P2860

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

http://www.wikidata.org/entity/Q34158520

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Specific human leukocyte antig ...... with hepatitis C virus viremia

@ast

Specific human leukocyte antig ...... with hepatitis C virus viremia

@en

Specific human leukocyte antig ...... with hepatitis C virus viremia

@nl

type

label

Specific human leukocyte antig ...... with hepatitis C virus viremia

@ast

Specific human leukocyte antig ...... with hepatitis C virus viremia

@en

Specific human leukocyte antig ...... with hepatitis C virus viremia

@nl

prefLabel

Specific human leukocyte antig ...... with hepatitis C virus viremia

@ast

Specific human leukocyte antig ...... with hepatitis C virus viremia

@en

Specific human leukocyte antig ...... with hepatitis C virus viremia

@nl

P1433

Q34158520-77D7DA57-76BE-41C3-907C-5BEF72748793

P1476

Q34158520-ECB53DBD-38CA-4F4C-A69B-45858FEC4F51

P2093

Q34158520-033FFEF2-EFD7-468E-B03F-3C7922D58AE1

Q34158520-05FE4AA2-1031-43DB-8F60-2C5C2A61B4B3

Q34158520-19ECFA4F-77C5-4CA6-9A0E-DBFD422699F5

Q34158520-2409825C-40CF-4F26-A677-953F9AD5F498

Q34158520-241304EF-5204-42BD-B755-5A88064811C3

Q34158520-2AE2818C-C0BC-4447-9410-15D014EA0BEA

Q34158520-2B855968-E120-4C34-94BF-6B711826B419

Q34158520-3D30BB51-66D1-489B-92A2-5120D627D395

Q34158520-3E98F31A-9898-4FE2-9FA8-639382EC2AD8

Q34158520-405F044B-3181-4063-A0CA-B25217E235FC

P2860

Q34158520-011E40FA-0D0D-40FC-85D5-BEEEFC572899

Q34158520-085520B2-6112-4618-B58F-C8E88B353341

Q34158520-0B6CCF6E-B7CE-42E7-9A71-60673CC30A5A

Q34158520-0DFD4DF7-4EDD-4401-A6C8-B5877328AF46

Q34158520-0F1616C9-B507-42A7-810D-738F97696A24

Q34158520-0FD88D25-0478-4CBA-9ED6-D1C0656FB2FB

Q34158520-10E5D71B-BEBB-478C-80D2-657DF21BCCA6

Q34158520-135A0D67-1B8E-466D-B9A8-CEF19057AD92

Q34158520-1970A044-9992-4DE7-8833-7D7D5156229D

Q34158520-1B37D4F1-E8F6-4606-8B2D-071B90753CFF

P304

Q34158520-A6CB24FE-1D34-4168-A1A6-8AC79D26933A

P31

Q34158520-C8610867-56E0-4E3A-965C-D79E027BBE89

P356

Q34158520-82685759-A873-45C8-940E-4DE5B25D7812

P407

Q34158520-AC123805-F142-47F8-9D0E-11D9F4270F97

P433

Q34158520-65A48DA5-6A93-445A-B096-90B63F394D7C

P478

Q34158520-50792C60-21DD-4B71-B100-69725B75581A

P50

Q34158520-17FA60C5-BBBF-4292-BD2E-7474D97B645E

Q34158520-D821BA14-7FA4-43DD-9A70-B20882F66911

Q34158520-E3D80FB0-4569-4F18-8405-614C1B89FF48

P577

Q34158520-92678506-F989-4C32-A975-0C85034E2138

P5875

Q34158520-F58DEC13-B311-4799-B614-4D9A5B05C470

P698

Q34158520-21A9F058-C7AC-4C08-BF41-63CAED352A0A

P932

Q34158520-E25E6F20-DA16-4CDE-9611-D287CE18679E

P356

P1433

P1476

Specific human leukocyte antig ...... with hepatitis C virus viremia

@en

P2093

Andrea Kovacs

http://www.w3.org/2001/XMLSchema#string

Chloe L Thio

http://www.w3.org/2001/XMLSchema#string

Darlene Marti

http://www.w3.org/2001/XMLSchema#string

Howard D Strickler

http://www.w3.org/2001/XMLSchema#string

Howard Minkoff

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

Kathryn Anastos

http://www.w3.org/2001/XMLSchema#string

Mardge H Cohen

http://www.w3.org/2001/XMLSchema#string

Marion G Peters

http://www.w3.org/2001/XMLSchema#string

Mark H Kuniholm

http://www.w3.org/2001/XMLSchema#string

P2860

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

HLA-Cw*04 and hepatitis C virus persistence.

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans

Determinants of viral clearance and persistence during acute hepatitis C virus infection

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

P304

1514-1522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23515

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

Melissa Fazzari

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41488258

http://www.w3.org/2001/XMLSchema#string

P698

20169624

http://www.w3.org/2001/XMLSchema#string

P932

2946382

http://www.w3.org/2001/XMLSchema#string